1. Introduction {#s0005}
===============

Prognostication in comatose patients after cardiac arrest (CA) relies heavily on the neurological examination to determine brain function, due to the fact that the extent of brain injury following CA often determines outcomes and costs for long-term care ([@b0100], [@b0105], [@b0145]). In particular, early post-hypoxic myoclonus (PHM) is of significant prognostic value ([@b0030], [@b0045]). PHM is defined as repetitive, generalized, focal or multifocal, motor myoclonic movements involving the face, limbs, or trunk that can occur at any time following CA, stemming from increased neuronal excitability after brain injury ([@b0030], [@b0045], [@b0140]). There are different forms of PHM, previously defined by timing of onset, termed "acute" and "chronic" ([@b0045]). "Acute" PHM (also referred to as myoclonus status epilepticus (MSE)) is the clinical appearance of nearly continuous myoclonic jerking for at least 30 min ([@b0105], [@b0145]). MSE was previously believed to indicate a poor prognosis ([@b0140], [@b0145], [@b0155]) but this is being challenged by increasing reports of cases with a favorable outcome ([@b0045], [@b0060], [@b0090], [@b0095], [@b0110], [@b0120]). Conversely, "chronic" PHM or Lance-Adams syndrome (LAS) portends a better prognosis ([@b0095]).

Unfortunately, PHM subtypes can be difficult to differentiate in the acute setting when sedatives may mask clinical and neurophysiological characteristics ([@b0045], [@b0060]). This can make diagnosis challenging, as clinical examination and neurophysiological testing are crucial in predicting future neurological function ([@b0115]) and may help define PHM subtypes and their associated outcomes ([@b0005], [@b0025], [@b0030], [@b0035], [@b0045], [@b0050], [@b0060], [@b0065], [@b0110], [@b0125], [@b0130], [@b0140], [@b0150]).

In this article we will review the defining characteristics of MSE and LAS. Our goal is to elucidate clinical and neurophysiological features that can allow for better differentiation between types of PHM, to enable earlier diagnosis and the institution of the appropriate management. We will also point out gaps in our understanding to guide further study.

2. Clinical features of PHM {#s0010}
===========================

Prior studies have attempted to define the various forms of PHM based on a number of clinical features. Unfortunately, many authors did not clearly distinguish LAS from MSE, and only recently have studies focused more closely on differentiating the two ([@b0030], [@b0045], [@b0060]). This distinction is key, because many cases previously described as "acute" PHM were later diagnosed as being LAS once the patient awakened ([@b0045], [@b0060]). Specific clinical indicators that have been studied to discriminate LAS and MSE, and to delineate subtypes of MSE include: time to onset of myoclonus after CA ([@b0005], [@b0060], [@b0095], [@b0125]), outcomes ([@b0005], [@b0030], [@b0035], [@b0075], [@b0085], [@b0095], [@b0100], [@b0110], [@b0120], [@b0140], [@b0155]), response to treatment ([@b0025], [@b0130], [@b0150]), clinical characteristics of myoclonus ([@b0005], [@b0035], [@b0060], [@b0070], [@b0065], [@b0125]), and neurologic exam with particular focus on the presence of coma ([@b0035]).

2.1. MSE {#s0015}
--------

MSE has been characterized as multifocal ([@b0005], [@b0035], [@b0060], [@b0125]) or generalized, massive jerking of the body ([@b0065]) and typically occurs within the first 72 h of CA ([@b0125]). It may last for days before resolving ([@b0060]). MSE is believed to originate in subcortical regions, likely from the brainstem, and can occur spontaneously, or be stimulus-sensitive ([@b0065]). MSE typically demonstrates bilateral synchronous myoclonus involving the sternocleidomastoid, trapezius, and facial muscles as well as of the trunk and limbs ([@b0035], [@b0070]). In generalized MSE, proximal musculature is often involved ([@b0070]), consistent with subcortical myoclonus ([@b0005]), although diffuse limb involvement may also be seen ([@b0125]). In patients with multifocal MSE, about half demonstrate proximal limb myoclonus, and 75% may have distal limb involvement ([@b0125]). It has been reported that multifocal MSE and generalized MSE can be reliably distinguished by clinical exam ([@b0125]), but these conclusions have not been validated and should be viewed with caution.

On examination, the patients are usually comatose. Though this is most often due to the severe neurologic insult, wakefulness is often masked by the concurrent use of sedatives for ventilator management in the acute setting after CA ([@b0035]). Therefore, examination is optimally performed during minimal sedation.

Treatment of MSE is not well established. Given the appearance of epileptiform activity both clinically and electroencephalographically, anti-seizure drugs (ASD) are often first line, with anesthetics used if these fail ([@b0060]). Clonazepam is often used, and serotoninergic medications have also been tried ([@b0065]) though myoclonus in MSE is usually difficult to treat ([@b0120]). Previously it was believed that the anatomic localization of myoclonus could be made based on the response to treatment, but has not been consistently demonstrated ([@b0025], [@b0130], [@b0150]).

The mortality in patients with MSE after CA ranges from 90 to 100% ([@b0005], [@b0030], [@b0100], [@b0110], [@b0120], [@b0140], [@b0155]). The chances of a good neurologic outcome in survivors is also low ([@b0110], [@b0120]). Some authors suggest that those with multifocal PHM may have better neurologic function and survival than generalized PHM ([@b0005]), but this has not been confirmed ([@b0125]). Better outcomes in multifocal PHM might be attributable to differences in the extent of brain injury, given that focal or multifocal PHM has a localized cortical origin ([@b0015], [@b0020]), whereas generalized PHM results from diffuse cortical injury ([@b0015], [@b0070]). This may also explain survival differences between LAS and MSE as LAS may have a more focal localization clinically and electro-encephalographically ([@b0030], [@b0045]). Further investigation into the outcomes of the different clinical forms of MSE is warranted.

Other clinical features that portend worse outcomes in CA are seen more commonly in patients with MSE. These include longer time to professional cardiopulmonary resuscitation, less frequent bystander resuscitation, and higher rates of non-shockable cardiac rhythm on presentation ([@b0110]). These clinical factors likely explain why MSE heralds a poor recovery. Further study should evaluate if these clinical indicators also help delineate MSE from LAS, and differentiate those with MSE who have disparate outcomes.

2.2. LAS {#s0020}
--------

LAS can be generalized or multifocal, and is intention and stimulus-induced ([@b0035], [@b0065]). The areas of the limb involved depend on whether or not myoclonus is from a cortical or subcortical source ([@b0005]). It has been noted previously that LAS presents later after CA than MSE ([@b0035]), and though it can occur months to years following CA, LAS has been seen within hours ([@b0045]). Hence, time to onset cannot reliably distinguish PHM subtypes.

LAS usually occurs once patients regain consciousness ([@b0090]). This delay in the clinical diagnosis of LAS is often due to the use of sedatives that mask alertness, thereby preventing intention or action myoclonus from being clinically evident ([@b0045], [@b0095], [@b0145]). The use of sedation early after CA makes clinical examination difficult as patients appear comatose, similar to those with MSE. As patients awaken, many neurologic domains remain intact, including cognition, though they may be left with significant cerebellar dysfunction and chronic myoclonus ([@b0035], [@b0075], [@b0085], [@b0095]).

Treatments for LAS are similar to those for MSE, including the use of the same ASDs ([@b0050]) and serotoninergic agents ([@b0055]). Differentiating subtypes of myoclonus based on the response to treatment is not well established, and further study is warranted before relying on clinical response for diagnosis and management.

Historically, patients diagnosed with LAS were thought to invariably survive CA ([@b0045]). However, this is likely due to survivorship bias as some patients with LAS have myoclonus soon after CA ([@b0030], [@b0045]), which may be confused with MSE and therefore lead to early withdrawal of ventilator support based on prior study that MSE consistently leads to poor outcomes after CA ([@b0110]). A recent study showed that 4/8 comatose patients with early post-arrest myoclonus who demonstrated similar electroencephalography (EEG) findings survived and were subsequently diagnosed with LAS ([@b0030]). Though patients who survive may live independently, many are unable to perform activities of daily living due to neurologic dysfunction or intention myoclonus ([@b0035], [@b0085]).

LAS is more commonly associated with respiratory arrest than a primary CA ([@b0045]). No other clinical distinction has been found regarding particulars of the CA itself.

3. Neurophysiologic features of PHM {#s0025}
===================================

The use of neurophysiological studies in the evaluation of PHM has been a focus of study given the difficulty in differentiating PHM subtypes in the acute setting based on clinical examination ([@b0015], [@b0020], [@b0030]). These studies can help delineate cortical and subcortical myoclonus, and diffuse versus focal epileptiform activity, which may be useful in defining subtypes of PHM and prognosis ([@b0010], [@b0030], [@b0060], [@b0125]). EEG itself may facilitate the diagnosis of LAS without the use of clinical characteristics ([@b0030]).

Cortical myoclonus is represented neurophysiologically by giant somatosensory evoked potentials (SSEPs) and jerk-locking, defined by a correlation between epileptiform discharges on the EEG and clinical myoclonus using concurrent electroencephalography-electromyography (EEG-EMG) polygraphy ([@b0005], [@b0015], [@b0020], [@b0065], [@b0120], [@b0150]). There may be false-negatives, since the lack of jerk-locking does not exclude cortical myoclonus given that the signal might be too small to register on EEG, or it may be obscured by high signal background noise ([@b0015]). Cortical myoclonus may also be characterized on EEG by diffuse abnormalities, including epileptiform activity ([@b0005], [@b0060], [@b0125]). However, others have explained these EEG findings as reflecting severe cortical injury with the subsequent disinhibition of a subcortical focus ([@b0015], [@b0070]).

Subcortical myoclonus can be differentiated from cortical myoclonus by the absence of giant SSEPs and the lack of jerk-locking on EEG-EMG polygraphy. On EEG, generalized epileptiform activity, such as periodic discharges, may also denote subcortical myoclonus ([@b0120], [@b0125]). EEG-EMG polygraphy during a myoclonic jerk may also reveal muscles innervated by lower brainstem nuclei, including the trapezius and sternocleidomastoid, being activated initially before spread to facial musculature ([@b0070]).

Ultimately, EEG is the most reliable and studied tool for evaluating PHM ([@b0060]). However, there is variability in EEG over time in the post-arrest period ([@b0030]) which is often not accounted for ([@b0045], [@b0040]), making it difficult to interpret and apply data from studies of EEG to define myoclonus.

3.1. MSE {#s0030}
--------

A previous review ([@b0060]) indicated two studies that pointed to a cortical origin for myoclonus in MSE ([@b0005], [@b0125]), whereas others have demonstrated a subcortical generator produced by disinhibition after diffuse cortical injury ([@b0070], [@b0065], [@b0150]). Neurophysiological features noted in these patients include normal or absent SSEPs ([@b0005], [@b0135], [@b0145]) lack of jerk-locking with EEG-EMG polygraphy ([@b0070], [@b0150]), and inconsistent correlation between clinical myoclonus and epileptiform activity on EEG without the use of EEG-EMG polygraphy ([@b0060]), all of which would suggest a subcortical source. Generalized epileptiform discharges and burst-suppression have been described ([@b0030], [@b0080], [@b0125], [@b0140]), and may portend a worse prognosis in MSE ([@b0110]). EEG can show burst-suppression early on, which may then evolve into generalized periodic discharges within 2--3 days of CA ([@b0030]). Intermittent or continuous spike-wave activity is also seen in these patients and can resemble status epilepticus ([@b0060], [@b0110]). Lateralized periodic discharges are not typically seen ([@b0140]), which is another indicator suggesting that the cortex may not be the source for myoclonus. When compared to CA survivors *without* PHM, those with MSE less commonly demonstrate generalized slowing ([@b0140]). Alpha coma has also been seen in some cases ([@b0060], [@b0140], [@b0155]), although this may only be present when the EEG is performed later in the clinical course after CA ([@b0140]).

Given the possible differences in outcomes in patients with multifocal versus generalized MSE ([@b0075]), neurophysiological testing has been investigated to help delineate these forms of MSE. Multifocal MSE is presumed to have a cortical origin based on EEG studies ([@b0015], [@b0020], [@b0125]). However, this has not been proven using SSEP and EMG-EEG polygraphy ([@b0125]). One study determined that generalized status epilepticus was more common in generalized MSE, while diffuse slowing was more likely seen in multifocal MSE ([@b0125]). Further study in this subpopulation is needed to elucidate the source of myoclonus, the differences in EEG characteristics, and to confirm their different prognoses.

3.2. LAS {#s0035}
--------

A recent review defined many of the EEG findings in LAS ([@b0045]). Epileptiform activity was noted in up to 1/3 of cases, and in half of these, spike or polyspike-wave discharges were noted primarily or maximally at the vertex ([Fig.1](#f0005){ref-type="fig"}A, B). Some cases also demonstrated normal EEGs between myoclonic jerks. A recent retrospective study of patients within the first 6--8 h of CA reported vertex-localized spike-waves on EEG in 12% of patients, of whom 50% survived with a favorable outcome and who were subsequently diagnosed as LAS based on clinical criteria ([@b0030]). These findings localize the phenomenon to the motor cortex and explain the manifestations of intention-induced myoclonus in those with LAS ([@b0055]). Other nonspecific EEG findings in LAS include diffuse or focal slowing, although about 20% were noted to have a normal EEG ([@b0045]).Fig. 1A. EEG on day 0 following cardiac arrest demonstrates narrow polyspikes and spikes predominantly in the midline and parasagittal regions. Adapted with permission from [@b0030]. B. EEG demonstrates spikes maximally at the midline. Adapted with permission from [@b0150].

Of those undergoing EEG-EMG polygraphy, about 60% demonstrated jerk-locking, denoting cortical myoclonus, which was further illustrated by SSEPs which showed a similar proportion of cortically-based myoclonus by the presence of "giant" SSEPs. However, there was a significant proportion demonstrating subcortically based myoclonus noted by the lack of jerk-locking on EEG-EMG polygraphy and normal sized SSEPs ([@b0045]).

It appears that localization to the cortical or subcortical regions is not helpful in defining LAS as both areas can be involved. However, if cortical myoclonus is unique to LAS then this finding might differentiate LAS from MSE, particularly the generalized phenotype. Further study should be performed to evaluate whether the presence of subcortical or cortical myoclonus in LAS affects outcome, and to confirm if the vertex epileptiform activity can be consistently demonstrated to represent LAS.

[Table 1](#t0005){ref-type="table"} provides a summary of the clinical neurophysiologic features of the different forms of PHM.Table 1Summary of clinical and EEG findings in PHM.MSELAS*Clinical features*Body parts involvedGeneralized or multifocal; trunk, trapezius, sternocleidomastoid, face, limbs; proximal and distal limb involvedGeneralized, multifocal, or focal; limb involvement depends on cortical vs. subcortical sourcesTiming of onsetRarely after 72 h post-cardiac arrestFrom hours to years following cardiac arrestLength of durationDays to weeksDays to yearsResponse to treatmentUsually poorVariableNeurologic examinationUsually comatoseComatose if sedated; awake, alert, and cognition may be relatively preservedMortality rate90--100% of casesUnclear given selection and survivorship bias, but in one retrospective study 50% of patients with similar EEG findings survivedGood neurologic outcomeRare, may be more likely with multifocal versus generalized MSECommonCircumstances of cardiac arrestLonger time to CPR, less bystander resuscitation, higher rates of non-shockable cardiac rhythm on presentationOften primary respiratory arrestStimulus-sensitivity of myoclonusYesYesSpontaneous myoclonusYesOccasionallyIntention myoclonusNoYes  *Neurophysiological findings*EEG findingsGeneralized epileptiform discharges and burst suppression, status epilepticus noted by intermittent or continuous spike-waves; lateralized periodic discharges and focal discharges are less common; over time burst suppression can evolved into generalized periodic discharges; diffuse slowing less common; alpha coma, particularly later after cardiac arrestEpileptiform activity in up to 1/3 of cases often maximally or primarily at the vertex especially within hours after cardiac arrest, can have normal background activity; diffuse or focal slowing; up to 20% are normalSSEPsNormal or absent; giant SSEPs not consistently demonstrated; lacking thorough evaluation of multifocal PHMCan demonstrate both giant and normal-sized SSEPsEEG-EMG polygraphyTypically lacks jerk-locking; a thorough evaluation of multifocal PHM is lackingJerk-locking has been noted in roughly 60% of cases  *Localization*Subcortical, possibly corticalBoth subcortical and cortical

4. Conclusions {#s0040}
==============

In this review, we discussed the clinical and neurophysiologic characteristics of "acute" and "chronic" PHM, or MSE and LAS, in order to better define these entities, because of their markedly different prognoses. Clinical distinction between different subtypes of PHM can be difficult in the acute post-arrest period when patients are subjected to sedating medications to allow ventilator support. Though differentiating cortical and subcortical myoclonus may be helpful, better definition of the EEG features that determine the severity of brain injury and that provide reliable prognoses, is needed. Neurophysiological studies may eventually enable an understanding of the pathophysiology underlying different forms of PHM, and provide help in differentiating those patients with good versus poor outcomes.
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